RECRUITINGPhase 3INTERVENTIONAL
Pulse Steroid Injection in Refractory Rheumatoid Arthritis
Revealing the Potential of Intravenous Pulse Steroid Therapy; Impressive Results in Attaining Remission or Low Disease Activity in Refractory Rheumatoid Arthritis
About This Trial
Remission or low disease activity in active rheumatoid arthritis
Who May Be Eligible (Plain English)
Who May Qualify:
- Refractory rheumatoid arthritis patients
Who Should NOT Join This Trial:
- Other connective tissue diseases
- Endocrine diseases such as DM and thyroid disorders
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* Refractory rheumatoid arthritis patients
Exclusion Criteria:
* Other connective tissue diseases
* Endocrine diseases such as DM and thyroid disorders
Treatments Being Tested
DRUG
Solumedrol
125 mg methylprednisolone intravenous pulse on 2 consecutive days
Locations (1)
Al-Azhar Univrsity
Cairo, Egypt